US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,567.99

-10.0364-0.64%

Number of Gainers:- -

Number of Losers:7

Number of Flat:- -

PE:- -

High:1,590.89

Open:1,579.34

Low:1,558.46

Close:1,578.03

Volume:63.28M

Turnover:5.40B

Market Cap:1.63T

Float Cap:1.57T

Loading ...

Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire

Amgen Says Dazodalibep Meets Primary Endpoint in Phase 3 Sjögren's Disease Trial

Amgen Shares up 3% After Co's Autoimmune Disease Drug Succeeds in Late-Stage Trial

THOMSON REUTERS

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Amgen Says Phase 3 Trial Shows Dazodalibep Cuts Systemic Disease Activity in Sjögren’s Disease

Amgen Announces Positive Topline Phase 3 Results for Dazodalibep in Moderate-to-Severe Systemic SjÖGren's Disease

THOMSON REUTERS

Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss

Sector Update: Healthcare

MT Newswires Live

Amgen: Dazodalibep Showed Statistically Significant & Clinically Meaningful Improvement in Systemic Disease Activity

THOMSON REUTERS

Amgen: Phase 3 Oasiz 303 Study of Dazodalibep in Moderate-to-Severe Symptomatic SjÖGren’s Disease Expected to Complete in Q4 2026

THOMSON REUTERS

Novo Nordisk (NVO) Receives a Hold from Jefferies

Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.

Viking Therapeutics Says Obesity Drug Showed 'Superior' Results in Study; Shares Jump

MT Newswires Live

Hope Fuels Markets but Reality Could Bite

Viking Therapeutics Reports Strong Obesity Drug Maintenance Data

Viking Therapeutics Shares Rise 38% Premarket After Experimental Drug Maintains Weight Loss in Study

THOMSON REUTERS

Viking Therapeutics' Obesity Drug Shows 22% Weight Loss in Study

Viking Therapeutics reports ‘positive’ results from maintenance study of VK2735

Viking Therapeutics Reports Vk2735 Maintenance Trial Keeps up to 97% of Weight Loss with Every-Other-Week Dosing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BK4599/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1567.9943,"timestamp":1790971199999,"preClose":1578.0306,"halted":0,"volume":63277927,"delay":0,"changeRate":-0.00636,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-10.036377,"latestTime":"10-02 16:00:00 EDT","open":1579.339,"high":1590.8905,"low":1558.4647,"amount":5402065307.321307,"amplitude":0.020548,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.58996,"peRate":28.239741,"turnoverRate":0.005949,"increases":0,"decrements":7,"flats":0,"marketCap":1628153847712,"floatMarketCap":1570705071680},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1590.8905,"amplitude":0.020548,"preClose":1578.0306,"low":1558.4647,"pbRate":"9.58996","latestPrice":1567.9943,"volume":63277927,"delay":0,"open":1579.339,"prevYearClose":1494.5856,"prevWeekClose":1622.7886,"prevMonthClose":1599.3274,"prevQuarterClose":1599.3274,"fiveDayClose":1622.7886,"twentyDayClose":1648.1235,"sixtyDayClose":1637.6415,"secType":"PLATE","market":"US","turnoverRate":0.005949,"peRate":28.239741,"marketCap":1628153847712,"floatMarketCap":1570705071680,"timestamp":1790971199999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":0,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669142790","title":"Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142790","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142790?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:47","pubTimestamp":1790084874,"startTime":"0","endTime":"0","summary":"Eli Lilly and Novo Nordisk have been locked in a fierce battle to corner the weight-loss market, and while it is effectively a duopoly now, emerging competitors could soon challenge their...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Viking Therapeutics Stock Surges. It Could Challenge Lilly and Novo's Obesity Empire","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225283273.USD","LU0823416689.USD","LU1093756325.SGD","LU0683600562.USD","LU0689472784.USD","PPH","MHIP","LU2168564149.EUR","LU2211815571.USD","SG9999015952.SGD","LU2237438978.USD","LU2746668461.USD","LU0133085943.USD","LU2471134952.CNY","LU0640476718.USD","LU0096364046.USD","LU2023250504.SGD","IE0004445015.USD","JDOC","LU1366192091.USD","LU1868837136.USD","IHE","IE00BJT1NW94.SGD","LU1064131342.USD","BK4007","IE00BKVL7J92.USD","FHLC","LU0323591593.USD","THNR","BK4585","SGXZ51526630.SGD","SG9999015978.USD","LU1057294990.SGD","LU2237443895.HKD","LU0345770993.USD","LU0882574055.USD","LU0471298694.HKD","LU1623119135.USD","LU1804176565.USD","NVOH","IE00B7KXQ091.USD","LU0198837287.USD","LU1868836914.USD","LU2461242641.AUD","XLV","LU2361044865.SGD","SGXZ57979304.SGD","LU0094547139.USD","LU1267930730.SGD","LU2237443978.SGD","LU0708995401.HKD","IE00BJLML261.HKD","LU0114720955.EUR","LU0345770308.USD","LU0353189763.USD","LU0385154629.USD","IE00B1XK9C88.USD","LU1093756168.USD","MEDI","LU0456855351.SGD","SG9999014880.SGD","GDOC","IXJ","RXL","LU0354030511.USD","BK4533","IE00BFSS8Q28.SGD","IE00B4R5TH58.HKD","LU1551013425.SGD","LU0097036916.USD","LU1061106388.HKD","IE00B775H168.HKD","LU0109394709.USD","ELIL","LU0320765992.SGD","LU2552382132.HKD","LU0158827948.USD","LU0432979614.USD","LU1979441026.SGD","IE00BWXC8680.SGD","TRUH","SG9999014914.USD","LU1720051108.HKD","IE00BKPKM429.USD","LU0889565916.HKD","LU0203202063.USD","NVOX","LU0964807845.USD","LU0256863902.USD","LU1323610961.USD","LU2168564065.EUR","ELIS","LU1814569148.SGD","LU0106261372.USD","IYH","LU2462157665.USD","LU2111349929.HKD","BK4139","IE00BJJMRX11.SGD","LU2168564495.EUR","FTXH","LU2168563687.JPY","LU2237443549.SGD","LU2063271972.USD","LU1989771016.USD","LU1629891620.HKD","LU0122379950.USD","LU2552382058.USD","SGXZ31699556.SGD","NVO","LU2324357040.USD","LU0158827781.USD","IE00BZ1G4Q59.USD","LLYZ","IE00BFTCPJ56.SGD","LU2471134879.HKD","IE00BK4W5M84.HKD","SG9999015945.SGD","LU2491050154.USD","LU0174119429.USD","SG9999017495.SGD","LU2491049909.HKD","LU2552382215.SGD","IE00B4JS1V06.HKD","LU0289739699.SGD","SG9999001176.SGD","LU0203201768.USD","LU2089984988.USD","LU2750360641.GBP","LU2896262040.SGD","LU2271345857.HKD","LU2089284900.SGD","LU2602419157.SGD","LU2491050071.SGD","HRTS","LU1127390331.HKD","LU2746668974.SGD","SG9999018865.SGD","BK4581","LU0256863811.USD","LU2471134796.USD","LU0471298777.SGD","LU2089283258.USD","SG9999014906.USD","LLY","LU0882574139.USD","LU2028103732.USD","LU2264538146.SGD","LLII","IE00BJJMRZ35.SGD","LU2456880835.USD","MEDX","LU2112291526.USD","LU0354030438.USD","LU0820561909.HKD","LU1232071149.USD","BK4534","IE00BN29S564.USD","LU1988902786.USD","LU2236285917.USD","LU2237443465.HKD","ILDR","LU2468319806.SGD","LU0061475181.USD","IE0009355771.USD","LU0234572021.USD","LU1280957306.USD","LU2237443382.USD","LU2756315318.SGD","VHT","BK4532","SGXZ99366536.SGD","LU0109391861.USD","AGNG","LU1868837300.USD","PJP","LU1691799644.USD","LU1548497426.USD","NVOC","LU0079474960.USD","LU2361045086.USD","LU0006306889.USD","LU2471134523.USD","TMED","LU2756315664.SGD","LU0238689110.USD","LU0320765059.SGD","LU2023250330.USD","BK4588","LU2265009873.SGD","IE00B2B36J28.USD","IE00BFSS7M15.SGD","CANC","IE0004445239.USD","LU2237443622.USD","VKTX","LU0787776722.HKD","SG9999014898.SGD","LU2417539215.USD","WDNA","IE0005OL40V9.USD","LU0316494557.USD","LU2361044949.HKD","LU2462591350.SGD","IE00B1BXHZ80.USD","LU1868836591.USD","LU1145028129.USD","BK4599","LU0210536198.USD","LU0786609619.USD","LU1917777945.USD","LU1720051017.SGD","LLYX","BK4516","GB00BDT5M118.USD","LU0417517546.SGD","LU0820562030.AUD","IE0002141913.USD","LU2357305700.SGD","SG9999018857.SGD","LU2023251221.USD","LU0672654240.SGD","IE00BJJMRY28.SGD","LU1069344957.HKD","IE00BK4W5L77.USD","IE00BKDWB100.SGD","LU2750360997.AUD","LU2106854487.HKD","LU1983299246.USD","LU0266013472.USD","CURE","LU1712237335.SGD","LU1291159041.SGD","LU0823434740.USD","LU1868836757.USD","LU2087625088.SGD","IE0001KFT4U8.USD","SG9999001176.USD","LU2108987350.USD","LU1974910355.USD","LU0154236417.USD","LU0353189680.USD","LU0058720904.USD","LU1023059063.AUD","SG9999015986.USD","LU0823434583.USD","LU1035775433.USD","LU0820561818.USD","LU2168564222.USD","LU2360106947.USD","SGXZ81514606.USD","LU1551013342.USD","OZEM","SG9999013999.USD","LU0943347566.SGD","LU2213496289.HKD","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147050","title":"Amgen Says Dazodalibep Meets Primary Endpoint in Phase 3 Sjögren's Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147050","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147050?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:45","pubTimestamp":1790084715,"startTime":"0","endTime":"0","summary":"Sept 22 (Reuters) - Amgen Inc::*AMGEN: PHASE 3 OASIZ 303 STUDY OF DAZODALIBEP IN MODERATE-TO-SEVERE SYMPTOMATIC SJGREN’S DISEASE EXPECTED TO COMPLETE IN Q4 2026*AMGEN: DAZODALIBEP MEETS PRIMARY ENDPOI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nRSDcc0x9T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","TBXU","PBE","LU2468319806.SGD","BK4599","IE0002141913.USD","IBB","LU0058720904.USD","LU0289739699.SGD","LU0320765992.SGD","BK4585","BK4581","BK4588","LU2112291526.USD","BK4566","BBH","IE00B2B36J28.USD","LU0868494617.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4534","LU0109394709.USD","LU0889565916.HKD","BK4139","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU2089984988.USD","AMGN","PJP","LU1571399168.USD","LU0122379950.USD","LU1983299246.USD","IBBQ","IE00B4R5TH58.HKD","LU1057294990.SGD","SG9999001440.SGD","LU1061106388.HKD","IE00BJT1NW94.SGD","LU2242646821.SGD","BIB","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147177","title":"Amgen Shares up 3% After Co's Autoimmune Disease Drug Succeeds in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147177?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:36","pubTimestamp":1790084178,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","LU0868494617.USD","LU0058720904.USD","LU0109394709.USD","BK4139","IE00B2B36J28.USD","BK4585","LU1057294990.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4599","BK4581","LU1983299246.USD","AMGN","SG9999001440.SGD","BK4588","IE0002141913.USD","LU1061106388.HKD","LU2468319806.SGD","TBXU","BK4533","LU1023059063.AUD","LU2112291526.USD","LU2089984988.USD","PJP","BIB","IBB","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2242646821.SGD","LU0122379950.USD","LU1571399168.USD","BK4566","IBBQ","IE0009355771.USD","LU0289739699.SGD","LU0889565916.HKD","PBE","LU2242652126.USD","IE00BJJMRZ35.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669472461","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669472461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669472461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:30","pubTimestamp":1790083809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lill...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pyxis-oncology-pyxs-moderna-mrna-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pyxis-oncology-pyxs-moderna-mrna-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1548497426.USD","LU2028103732.USD","BK4551","LU2896262040.SGD","LU1868836591.USD","VHT","SG9999015978.USD","LU1127390331.HKD","IE00BFSS8Q28.SGD","LU0225283273.USD","LU0316494557.USD","LU2168563687.JPY","LU2461242641.AUD","LU0238689110.USD","LU0256863902.USD","LU1804176565.USD","LU1814569148.SGD","IE00B4R5TH58.HKD","LU1917777945.USD","LU1989771016.USD","BK4568","FHLC","LU2108987350.USD","LU2471134523.USD","ELIL","MEDI","SG9999017495.SGD","IE00B1BXHZ80.USD","LU2417539215.USD","LU2471134952.CNY","LU1629891620.HKD","BK4588","WDNA","BK4599","LU2236285917.USD","LU1145028129.USD","IE00BWXC8680.SGD","LU0320765992.SGD","LU2552382215.SGD","LU2602419157.SGD","LU2750360997.AUD","SG9999018865.SGD","LU2324357040.USD","LU2087625088.SGD","IE00BJJMRX11.SGD","LU0096364046.USD","LU0820561818.USD","SG9999015986.USD","LU1974910355.USD","LU2746668974.SGD","LU0353189680.USD","LU0345770993.USD","LU2237438978.USD","LU1691799644.USD","LU2357305700.SGD","LU2456880835.USD","LU1712237335.SGD","SG9999015952.SGD","LU0820562030.AUD","IE00BJT1NW94.SGD","LU2023251221.USD","LU2471134796.USD","IE0009355771.USD","LU2361045086.USD","LU0114720955.EUR","LU0385154629.USD","LU2468319806.SGD","IE00BJJMRY28.SGD","BK4585","IE00BJJMRZ35.SGD","CURE","IE00B4JS1V06.HKD","IYH","LU0882574055.USD","LU2211815571.USD","LU2361044949.HKD","BK4532","GNOM","IE00BK4W5M84.HKD","LU0432979614.USD","LU2237443622.USD","LU1093756325.SGD","LU2213496289.HKD","PYXS","LU2750360641.GBP","LU0174119429.USD","LU0471298777.SGD","LU0820561909.HKD","LU0109391861.USD","LU0943347566.SGD","LU2237443465.HKD","TRUH","IE00BFSS7M15.SGD","LLII","LU1232071149.USD","CANC","LU0122379950.USD","LU2471134879.HKD","LU2746668461.USD","MEDX","SG9999014898.SGD","SG9999014906.USD","LU2271345857.HKD","LLYZ","BK4007","IE0004445015.USD","LU2168564222.USD","LU0079474960.USD","LU0823434583.USD","LU0354030438.USD","LU0109394709.USD","IE00BKDWB100.SGD","LU1064131342.USD","LU2264538146.SGD","LU2462591350.SGD","LU0353189763.USD","LU1868837300.USD","SGXZ51526630.SGD","LU1267930730.SGD","LU2265009873.SGD","LU1061106388.HKD","LU1623119135.USD","ELIS","LU0471298694.HKD","LLY","LU2089284900.SGD","PPH","LU0640476718.USD","LU2237443549.SGD","LU0345770308.USD","LU1720051017.SGD","LU0266013472.USD","IE00B775H168.HKD","LU1366192091.USD","BK4139","OZEM","LU0689472784.USD","LU0097036916.USD","LU0708995401.HKD","TMED","LU2089984988.USD","LU2168564065.EUR","LU0210536198.USD","LU2552382132.HKD","LU2756315318.SGD","RXL","LU0964807845.USD","SGXZ81514606.USD","LU2237443895.HKD","LU2106854487.HKD","LU1035775433.USD","SGXZ31699556.SGD","LLYX","LU0354030511.USD","LU1988902786.USD","LU0787776722.HKD","MHIP","GDOC","LU2063271972.USD","LU0158827781.USD","BK4534","LU0323591593.USD","FTXH","LU2023250504.SGD","LU0061475181.USD","SG9999001176.USD","GB00BDT5M118.USD","LU1323610961.USD","JDOC","THNR","LGHT","SGXZ99366536.SGD","SG9999015945.SGD","IXJ","LU2111349929.HKD","LU0417517546.SGD","AGNG","SGXZ57979304.SGD","LU1069344957.HKD","LU0823434740.USD","LU1983299246.USD","IE00BJLML261.HKD","MRNX","IE00BN29S564.USD","LU2360106947.USD","BK4533","LU1093756168.USD","IE00B1XK9C88.USD","LU1551013342.USD","LU2089283258.USD","SG9999013999.USD","IE00BFTCPJ56.SGD","LU0203202063.USD","SG9999014880.SGD","IE0004445239.USD","LU0203201768.USD","LU0256863811.USD","LU0882574139.USD","LU0158827948.USD","HRTS","LU1868836914.USD","MRNY","BK4581","IE00BK4W5L77.USD","LU2168564149.EUR","LU0786609619.USD","ILDR","LU0289739699.SGD","LU0133085943.USD","LU2552382058.USD","LU0058720904.USD","LU0456855351.SGD","LU0672654240.SGD","LU2168564495.EUR","IE00BKPKM429.USD","LU2023250330.USD","IE00B7KXQ091.USD","LU0889565916.HKD","LU2112291526.USD","LU2491049909.HKD","LU2237443382.USD","LU0198837287.USD","LU1868836757.USD","IE0002141913.USD","MRNA","IE0001KFT4U8.USD","LU1057294990.SGD","LU1280957306.USD","LU1551013425.SGD","SG9999014914.USD","LU0823416689.USD","SG9999018857.SGD","LU0683600562.USD","PJP","LU2361044865.SGD","IDNA","LU0320765059.SGD","LU1979441026.SGD","LU1291159041.SGD","BK4501","IE0005OL40V9.USD","LU1720051108.HKD","LU2237443978.SGD","LU0006306889.USD","LU2491050154.USD","LU2756315664.SGD","LU0466842654.USD","LU2491050071.SGD","IHE","IE00B2B36J28.USD","LU1868837136.USD","BK4516","LU0234572021.USD","LU2462157665.USD","LU0106261372.USD","SG9999001176.SGD","LU1023059063.AUD","LU0094547139.USD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142751","title":"Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142751","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142751?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:06","pubTimestamp":1790082402,"startTime":"0","endTime":"0","summary":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats upSept 22 (Reuters)-The weight-loss drug market is booming, with biotech firms racing to capture a slice of the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0O6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLII","LU1989771016.USD","NVOX","LU1868837300.USD","SG9999018857.SGD","LU0823434583.USD","LU2468319806.SGD","BK4585","LU1145028129.USD","IE0001KFT4U8.USD","BK4588","IE00B7KXQ091.USD","ELIS","LU2108987350.USD","LU0354030511.USD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU1868836914.USD","SG9999014914.USD","GDOC","LU0061475181.USD","LU2471134879.HKD","LU0889565916.HKD","BK4532","LU2361044865.SGD","LU1023059063.AUD","LU0203202063.USD","LU2746668974.SGD","SG9999013999.USD","LU0320765059.SGD","LU0466842654.USD","LU1720051017.SGD","OZEM","LU2089284900.SGD","LU2491050154.USD","SGXZ51526630.SGD","SG9999018865.SGD","LU0079474960.USD","IE0002141913.USD","JDOC","LU1061106388.HKD","IXJ","IE00BJJMRX11.SGD","LU0225283273.USD","LU2111349929.HKD","LU2168563687.JPY","LU1712237335.SGD","LU1814569148.SGD","LU2456880835.USD","LU2106854487.HKD","PPH","LU1366192091.USD","LU2023250504.SGD","BK4599","IE00BZ1G4Q59.USD","VHT","LU0471298777.SGD","AGNG","LU2237443622.USD","LU0109394709.USD","LU2168564222.USD","LU2168564495.EUR","LU2462591350.SGD","IE0009355771.USD","LU0094547139.USD","IE00BKDWB100.SGD","SG9999017495.SGD","FHLC","LU2471134796.USD","IE0005OL40V9.USD","LU2552382215.SGD","LU1868837136.USD","MHIP","LU0683600562.USD","LU1974910355.USD","LU0096364046.USD","CURE","SGXZ57979304.SGD","LU0786609619.USD","IE00BFSS8Q28.SGD","BK4581","NVO","LU0787776722.HKD","LU1868836591.USD","LU0058720904.USD","LLYZ","LU0174119429.USD","LU2168564149.EUR","IE00BJJMRY28.SGD","LU2265009873.SGD","LU2471134952.CNY","XLV","LU0133085943.USD","LU2360106947.USD","LU0882574055.USD","HRTS","TMED","IE0004445015.USD","LU0689472784.USD","IE0004445239.USD","LU0256863811.USD","LU0672654240.SGD","SG9999014906.USD","SGXZ81514606.USD","LU0820561818.USD","LU2324357040.USD","LU2063271972.USD","LU0823416689.USD","LU0353189680.USD","IE00B1XK9C88.USD","RXL","PJP","SG9999001176.USD","LU0345770308.USD","SG9999014880.SGD","LU0266013472.USD","LU0456855351.SGD","LU2168564065.EUR","LU2750360641.GBP","LU1551013342.USD","GB00BDT5M118.USD","LU2461242641.AUD","LU2471134523.USD","LU0203201768.USD","LU1069344957.HKD","LU2756315664.SGD","IE00BKVL7J92.USD","LU1323610961.USD","LU0882574139.USD","IE00BFSS7M15.SGD","LU0198837287.USD","LU0943347566.SGD","LU0471298694.HKD","LU0234572021.USD","LU2361044949.HKD","LU0006306889.USD","LU0353189763.USD","LU1868836757.USD","LU1232071149.USD","LU2089984988.USD","BK4534","LU1057294990.SGD","NVOH","LU2491050071.SGD","LU2896262040.SGD","LU2023250330.USD","LU0964807845.USD","LU0320765992.SGD","LU2237443549.SGD","MEDX","LU1720051108.HKD","LU2746668461.USD","LU0354030438.USD","IE00BFTCPJ56.SGD","LU0708995401.HKD","LU2236285917.USD","LU0385154629.USD","LU0158827781.USD","IHE","LU1267930730.SGD","SG9999001176.SGD","LU0417517546.SGD","LU0106261372.USD","LU2417539215.USD","TRUH","ILDR","SGXZ99366536.SGD","LU0345770993.USD","LU0820562030.AUD","SG9999015986.USD","LU1623119135.USD","LU0154236417.USD","LU2491049909.HKD","IE00BK4W5M84.HKD","CANC","LU1551013425.SGD","LU0640476718.USD","LU2237443978.SGD","WDNA","IE00BJT1NW94.SGD","SGXZ31699556.SGD","LU1064131342.USD","LU0109391861.USD","LU2112291526.USD","LU2361045086.USD","LU2750360997.AUD","LU2462157665.USD","LU2211815571.USD","LU0114720955.EUR","IE00BWXC8680.SGD","SG9999015978.USD","LU0238689110.USD","SG9999014898.SGD","LU0256863902.USD","LU2213496289.HKD","LU2237443382.USD","IYH","LU0122379950.USD","LU1127390331.HKD","LU2028103732.USD","IE00B2B36J28.USD","LU2089283258.USD","FTXH","LU1093756168.USD","BK4533","LU2271345857.HKD","LU0316494557.USD","IE00B4JS1V06.HKD","LU2087625088.SGD","LU1548497426.USD","SG9999015945.SGD","LU0210536198.USD","LU1291159041.SGD","BK4516","LLY","IE00BK4W5L77.USD","LU0432979614.USD","BK4007","LU1691799644.USD","LU2023251221.USD","LU2602419157.SGD","NVOC","IE00BN29S564.USD","MEDI","IE00BJLML261.HKD","LU0158827948.USD","LU1035775433.USD","LU0097036916.USD","LU1804176565.USD","LLYX","THNR","LU2237443895.HKD","IE00BKPKM429.USD","LU2756315318.SGD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU2237438978.USD","LU2264538146.SGD","LU0289739699.SGD","LU1988902786.USD","LU1629891620.HKD","LU1983299246.USD","LU1093756325.SGD","SG9999015952.SGD","LU1979441026.SGD","IE00B1BXHZ80.USD","LU2552382058.USD","LU2552382132.HKD","LU2357305700.SGD","IE00B775H168.HKD","LU1280957306.USD","LU0323591593.USD","LU1917777945.USD","ELIL","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669414223","title":"Amgen Says Phase 3 Trial Shows Dazodalibep Cuts Systemic Disease Activity in Sjögren’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2669414223","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669414223?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:04","pubTimestamp":1790082271,"startTime":"0","endTime":"0","summary":"Amgen says Phase 3 trial shows dazodalibep cuts systemic disease activity in Sjgren’s diseaseAmgen reported positive topline Phase 3 results for dazodalibep in adults with moderate-to-severe systemic ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL63L4Jz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","SG9999001440.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU2089984988.USD","LU2242652126.USD","BK4566","LU0868494617.USD","BBH","LU1571399168.USD","BK4599","IE00BFTCPJ56.SGD","BIB","LU1983299246.USD","LU2112291526.USD","IBB","BK4585","BK4534","LU0058720904.USD","IE0002141913.USD","BK4533","BK4588","BK4581","LU0289739699.SGD","LU1061106388.HKD","IE00B4R5TH58.HKD","AMGN","IE0009355771.USD","LU0109394709.USD","LU0122379950.USD","LU2468319806.SGD","BK4139","LU1057294990.SGD","PJP","LU2242646821.SGD","TBXU","PBE","IBBQ","IE00BJT1NW94.SGD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142967","title":"Amgen Announces Positive Topline Phase 3 Results for Dazodalibep in Moderate-to-Severe Systemic SjÖGren's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142967?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082029,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0FE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIB","LU0889565916.HKD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4139","LU0122379950.USD","IE0002141913.USD","PBE","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0289739699.SGD","BK4599","IE00BJJMRZ35.SGD","LU0868494617.USD","LU2112291526.USD","LU1061106388.HKD","IE00B2B36J28.USD","LU2242646821.SGD","LU0058720904.USD","LU1057294990.SGD","LU1571399168.USD","PJP","LU2242652126.USD","BK4588","IE0009355771.USD","LU1983299246.USD","LU0320765992.SGD","BK4533","SG9999001440.SGD","LU2089984988.USD","BBH","AMGN","IBBQ","BK4566","LU0109394709.USD","BK4581","IBB","BK4585","TBXU","IE00BJT1NW94.SGD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174429461","title":"Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1174429461","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174429461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082018,"startTime":"0","endTime":"0","summary":"Viking Therapeutics (VKTX.US) saw its shares spike nearly 50% in Tuesday's premarket trading after the biotech announced that its experimental obesity drug, VK2735, helped patients maintain most of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURE","FHLC","BK4539","BK4599","BK4007","BK4585","VKTX","BK4139","NVOX","RSPH","LENZ","NBDS","PJP","NVOH","OZEM","BK4588","PINK","TRUH","FXH","MEDI","XLVI","NVOC","THNR","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669935142","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2669935142","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669935142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082001,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF  0.2% lower and the iShares Biotechnology ETF  up 0.6%.Viking Therapeutics  shares were up more than 23% after the company said its subcutaneous VK2735 showed \"superior weight maintenance\" under less frequent dosing regiments compared to placebo over a 12-week period in a clinical study.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4599","BK4588","HCSG","BK4139","IBB","OZEM","BK4137","LABU","BK4581","VKTX","LU0029874061.USD","LU0128526141.USD","XLV","XBI","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142945","title":"Amgen: Dazodalibep Showed Statistically Significant & Clinically Meaningful Improvement in Systemic Disease Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142945?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nP8N3Z20GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU0122379950.USD","LU2242652126.USD","BK4566","IE00BJJMRZ35.SGD","LU2242646821.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4139","BK4533","TBXU","LU2089984988.USD","BK4581","LU0889565916.HKD","LU0320765992.SGD","IE00B2B36J28.USD","PJP","LU0289739699.SGD","LU1061106388.HKD","SG9999001440.SGD","BIB","LU1571399168.USD","IBB","BK4534","LU0868494617.USD","LU1983299246.USD","IE00BJT1NW94.SGD","BBH","LU0109394709.USD","BK4599","IE00B4R5TH58.HKD","LU2112291526.USD","PBE","LU1057294990.SGD","AMGN","IE0009355771.USD","BK4588","LU2468319806.SGD","LU0058720904.USD","LU1023059063.AUD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142617","title":"Amgen: Phase 3 Oasiz 303 Study of Dazodalibep in Moderate-to-Severe Symptomatic SjÖGren’s Disease Expected to Complete in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142617?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nP8N3Z20GZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","PJP","BBH","BIB","BK4534","LU2468319806.SGD","BK4581","LU1571399168.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4599","BK4588","LU0320765992.SGD","BK4585","IE0002141913.USD","LU0109394709.USD","LU2242646821.SGD","LU0868494617.USD","IE0009355771.USD","LU1023059063.AUD","AMGN","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1057294990.SGD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","LU1983299246.USD","BK4533","LU0289739699.SGD","IBBQ","PBE","BK4139","BK4566","LU2242652126.USD","LU2112291526.USD","SG9999001440.SGD","TBXU","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142475","title":"Novo Nordisk (NVO) Receives a Hold from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142475","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142475?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:56","pubTimestamp":1790081803,"startTime":"0","endTime":"0","summary":"Jefferies analyst maintained a Hold rating on Novo Nordisk today and set a price target of $42.20. In addition to Jefferies, Novo Nordisk also rece...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-nvo-receives-a-hold-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-nvo-receives-a-hold-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVOC","LU1093756325.SGD","BK4599","IE00BKVL7J92.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","NVO","NVOX","OZEM","PPH","THNR","BK4588","BK4532","NVOH","BK4007","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669445261","title":"Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669445261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669445261?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:22","pubTimestamp":1790079720,"startTime":"0","endTime":"0","summary":"Eli Lilly and Novo Nordisk have been locked in a fierce battle to corner the weight-loss market, and while it is effectively a duopoly now emerging competitors could soon challenge their lead.Seizing ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","ELIS","GB00BDT5M118.USD","LU0203202063.USD","LU2552382215.SGD","LU2089283258.USD","LU0094547139.USD","LU0672654240.SGD","LU1720051108.HKD","LLY","LU2361044865.SGD","LU0466842654.USD","LU0683600562.USD","IXJ","XLV","LU0106261372.USD","LU1064131342.USD","SG9999015986.USD","LU0122379950.USD","LU2491049909.HKD","LU2211815571.USD","LU2461242641.AUD","BK4599","IE00B1BXHZ80.USD","IE00BWXC8680.SGD","LU2106854487.HKD","LU1093756168.USD","IE00B4JS1V06.HKD","LU0354030438.USD","SG9999018857.SGD","LU2237443895.HKD","LU1979441026.SGD","RXL","LU0234572021.USD","LU0820561909.HKD","LU1814569148.SGD","ELIL","LU0210536198.USD","LU0417517546.SGD","LU2237443622.USD","LU2417539215.USD","LU2750360997.AUD","SG9999001176.SGD","LU0964807845.USD","LU2468319806.SGD","SGXZ51526630.SGD","LU0198837287.USD","LU1366192091.USD","LU2237443465.HKD","LU2471134796.USD","LU1127390331.HKD","LU2456880835.USD","LU0823416689.USD","IE00B4R5TH58.HKD","LU2462591350.SGD","LU0882574055.USD","LU0689472784.USD","SG9999001176.USD","LU1804176565.USD","IE00B2B36J28.USD","CURE","IE00BFSS8Q28.SGD","LU2168563687.JPY","LU2746668461.USD","LU2111349929.HKD","LU2357305700.SGD","LU0786609619.USD","LU0787776722.HKD","LU2168564149.EUR","LU2756315318.SGD","SG9999015952.SGD","FHLC","IE00BKPKM429.USD","IE00BJT1NW94.SGD","LU0097036916.USD","LU2023250330.USD","LU2237438978.USD","IE0004445015.USD","LU0133085943.USD","LU0203201768.USD","LU2237443549.SGD","LU2491050154.USD","LU0061475181.USD","BK4585","BK4588","LU0316494557.USD","SGXZ31699556.SGD","IE00BK4W5M84.HKD","IE0004445239.USD","LU1691799644.USD","LU1712237335.SGD","SGXZ57979304.SGD","LU2028103732.USD","IE0001KFT4U8.USD","LU2471134879.HKD","WDNA","LU0114720955.EUR","LU0158827781.USD","IE00BK4W5L77.USD","LU2063271972.USD","LU1629891620.HKD","LU1983299246.USD","GDOC","OZEM","IE0005OL40V9.USD","LU2602419157.SGD","RHHBY","IE00BKVL7J92.USD","IHE","LU2552382132.HKD","LU2360106947.USD","IE0009355771.USD","LU0820562030.AUD","NVOH","LU2462157665.USD","LU1548497426.USD","LU1551013425.SGD","IE00BJJMRZ35.SGD","LU2213496289.HKD","LU1868837136.USD","LU1232071149.USD","LU2746668974.SGD","LU1868836757.USD","MEDX","LU0256863902.USD","LU0432979614.USD","LU1093756325.SGD","LU1323610961.USD","LU1868836914.USD","LU2168564222.USD","IE00BN29S564.USD","LU1057294990.SGD","FTXH","IE00BJJMRX11.SGD","IE00BJJMRY28.SGD","LU2168564495.EUR","LU0882574139.USD","LU1917777945.USD","LU0820561818.USD","LU0154236417.USD","SGXZ81514606.USD","LU0456855351.SGD","TMED","LU0345770993.USD","LU1061106388.HKD","LU1720051017.SGD","LU2089984988.USD","LU2265009873.SGD","NVO","LU2089284900.SGD","LU2237443382.USD","MEDI","IE00BFSS7M15.SGD","SG9999018865.SGD","THNR","LU0943347566.SGD","LU2168564065.EUR","LU1974910355.USD","HRTS","LU0096364046.USD","LU0385154629.USD","LU1623119135.USD","LU2237443978.SGD","LU0238689110.USD","LU1145028129.USD","LU2471134523.USD","PJP","LU0823434583.USD","BK4534","IE0002141913.USD","03165","SGXZ99366536.SGD","LU2271345857.HKD","LU2023250504.SGD","AGNG","MHIP","BK4532","SG9999014898.SGD","LU2756315664.SGD","SG9999015978.USD","ILDR","JDOC","LU0320765992.SGD","LU2491050071.SGD","LU1035775433.USD","LU1023059063.AUD","TRUH","LU1868836591.USD","LU0058720904.USD","IE00B1XK9C88.USD","LU2236285917.USD","LU2896262040.SGD","LU1551013342.USD","LU2324357040.USD","IE00B7KXQ091.USD","LU0823434740.USD","LU1989771016.USD","LU1988902786.USD","SG9999014914.USD","LLII","VKTX","LU2552382058.USD","LU1069344957.HKD","LU1267930730.SGD","LU0353189680.USD","SG9999013999.USD","IYH","LU0471298694.HKD","LU0174119429.USD","LU1291159041.SGD","IE00BJLML261.HKD","IE00BKDWB100.SGD","LU0079474960.USD","LU2023251221.USD","LU2750360641.GBP","NVOX","LU0320765059.SGD","BK4007","LU0471298777.SGD","LU2087625088.SGD","LLYX","LU0889565916.HKD","BK4533","LU2112291526.USD","BK4581","LU2361045086.USD","LU0708995401.HKD","LU2361044949.HKD","VHT","LU0640476718.USD","LU0323591593.USD","LU0109394709.USD","LU0345770308.USD","SG9999014906.USD","LU1280957306.USD","SG9999014880.SGD","LU0354030511.USD","IE00B775H168.HKD","LU0158827948.USD","LU0225283273.USD","CANC","NVOC","LU0353189763.USD","BK4516","SG9999015945.SGD","BK4139","LU0109391861.USD","IE00BZ1G4Q59.USD","LLYZ","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU1868837300.USD","LU2108987350.USD","LU0266013472.USD","LU2264538146.SGD","LU2471134952.CNY","SG9999017495.SGD","LU0256863811.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144843","title":"Viking Therapeutics Says Obesity Drug Showed 'Superior' Results in Study; Shares Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144843","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144843?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:17","pubTimestamp":1790079477,"startTime":"0","endTime":"0","summary":"Viking Therapeutics  said Tuesday its subcutaneous VK2735 showed \"superior weight maintenance\" under less frequent dosing regiments compared to placebo over a 12-week period in a clinical study.Participants randomized to monthly dosing regimens preserved up to 90% of mean weight loss achieved during the induction period, the company said.VK2735 also demonstrated an \"encouraging safety and tolerability profile,\" Viking said.The company said it plans to explore oral dosing regimens in part 2 of the study.Shares of Viking Therapeutics were up more than 36% in premarket trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VKTX","THNR","BK4588","BK4585","BK4139","BK4599","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141342","title":"Hope Fuels Markets but Reality Could Bite","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141342","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141342?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:51","pubTimestamp":1790077860,"startTime":"0","endTime":"0","summary":"Good morning and welcome to another hopeful day for markets as Iran lifts Wall Street's spirits.Stocks looked set to continue their positive start to the week as falling oil prices seemed to offset a ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336760.USD","IE0034235303.USD","IE0002270589.USD","IE0004445015.USD","IE00BJJMRX11.SGD","LU2023250504.SGD","METG","METW","LU1699723380.USD","LU0787776722.HKD","CBOJ","IDRV","CBXJ","MNRS","LU0552385451.USD","LU1935042991.SGD","LU1303367103.USD","SGXZ51526630.SGD","LU1989764664.SGD","DFII","SGXZ99366536.SGD","IE00BSNM7G36.USD","LU0323591593.USD","LU0072461881.USD","LU0433182093.SGD","IE00B19Z3581.USD","LU2148611432.USD","BK4602","LU2458330243.SGD","LU1564329032.USD","BRRR","LU1069344957.HKD","LU0056508442.USD","LU0174119429.USD","04335","LU1951200564.SGD","LU0211331839.USD","LU0096364046.USD","LU2357305700.SGD","IE00BMPRXR70.SGD","LU0823414478.USD","LU0077335932.USD","LU0154236417.USD","LU2361044865.SGD","LU2168564065.EUR","BK4592","BK4566","LU2420271590.USD","LU1093756168.USD","BCCC","DEFI","IE00BJJMRY28.SGD","LU1093756325.SGD","LU0149725797.USD","IE00B5949003.HKD","LU2272731782.SGD","LU2463028550.USD","LU2244417387.USD","IE00B1BXHZ80.USD","LU2237957902.USD","LU2487616109.SGD","LU0081259029.USD","XBTY","LTL","LU0130517989.USD","GXPC","TSLT","LU2106854487.HKD","LU1064131342.USD","LU0082616367.USD","LU0310799852.SGD","LU2317271919.USD","LU1778281490.HKD","CBOY","SG9999015978.USD","HODL","LU1267930730.SGD","LU1815333072.USD","BTRN","LU1316542783.SGD","LU2087625088.SGD","BAGY","LU2430703178.SGD","LU0210528500.USD","GBTC","LU2065171311.SGD","BK4574","LU0256863811.USD","VOX","LU0321505439.SGD","LU0708995401.HKD","LU1670711123.USD","LU0882574139.USD","TSLR","BK4529","LU0097036916.USD","AMUU","LU2097829019.USD","HK0000304805.HKD","QQQA","LU1066051498.USD","LU1301847155.USD","SG9999004303.SGD","LU0203345920.USD","LU0820561909.HKD","SG9999018857.SGD","LU0061475181.USD","PSI","SG9999002232.USD","LU1880398471.USD","LU1674673691.USD","LU0130102774.USD","LU1066053197.SGD","LU2089985449.USD","LU2471134952.CNY","YBTC","LU0208291251.USD","LU1670710588.SGD","LU2290526834.HKD","BK4141","AMD","LU2065171402.SGD","OGIG","LU1074936037.SGD","WATS","LU2552382058.USD","LU0528227936.USD","LU0792757196.USD","LU0068578508.USD","IE00BMPRXQ63.HKD","GAMR","LU2168564222.USD","AIS","LU2404859667.USD","LU0353189763.USD","LU2355687059.USD","LU0784384876.USD","LU2404859741.USD","META","LU1861558580.USD","BK4007","NULC","LU0444971666.USD","MAXI","METU","IE00BJTD4V19.USD","LU1880398554.USD","INTW","AMDC","BITX","WISE","LU1670628061.USD","IE0003U64NQ7.SGD","CHAT","LU0061474960.USD","IE00BWXC8680.SGD","LU0964807845.USD","CRSH","SMOG","LU0210533765.USD","LU0210536198.USD","LU1267930227.SGD","SGXZ31699556.SGD","LU1814569148.SGD","HK0000304797.USD","LU0724617625.USD","IE00B4YYXB79.USD","LU2360106780.USD","FBY","LU1823568750.SGD","IE00B3SWFQ91.USD","LU2473716301.USD","IE00BKDWB100.SGD","LU2860962120.EUR","ELOL","LU2125154778.USD","LU2236285917.USD","LU1489326972.SGD","LU2505996509.AUD","LU2265009873.SGD","LU0823421333.USD","IE00B19Z8X17.USD","LU2720916845.USD","BK4527","BK4588","LU0823434740.USD","LU1720051017.SGD","LU0162691827.USD","LU1267930490.SGD","LU1366192091.USD","LU0859254822.USD","IE0009356076.USD","OZEM","FTXL","IE000MB6IJN5.SGD","LU0080751232.USD","07766","LU0823434583.USD","LU1119994496.HKD","IE00B19Z8W00.USD","SOXX","LU2023250843.SGD","IE000M9KFDE8.USD","BTCL","LU0310800965.SGD","SMETAmain","SG9999015986.USD","BK4581","LU1861220033.SGD","LU0265550359.USD","CBXO","LU2322448957.HKD","LU0788109477.HKD","LU1429558221.USD","TESC","GB00B4QBRK32.GBP","TEK","LU0203201768.USD","LU0353189680.USD","BK4551","IE00BQXX3F31.USD","TSLQ","TSII","LU0476273544.USD","TRFK","LU2063271972.USD","LU0170899867.USD","IE00BK4W5M84.HKD","LU2471134523.USD","LU1242518931.SGD","LU0251142724.SGD","LU1979441026.SGD","LU1732799900.SGD","WBD","LU2242650005.HKD","SG9999014906.USD","AMDU","BK4532","HK0000914660.USD","LU0689472784.USD","TESL","IE000W1ABFV2.USD","LU0070217475.USD","NVOH","LU1127390331.HKD","LU2168564149.EUR","TSLG","CBTJ","LU0006306889.USD","LU0823411888.USD","LU1914381329.SGD","LU0784385840.USD","LU1201861249.SGD","LU1280957306.USD","LU0444973449.USD","IE0009G5SDU7.USD","GB00BDT5M118.USD","LU0690374615.EUR","BTCZ","LU2746668974.SGD","LU1046421795.USD","IETC","LU0128525689.USD","LU0348723411.USD","IE00BMPRXN33.USD","SG9999015945.SGD","LU1564329115.USD","LU2764262908.HKD","TSLA","CBOO","LU1564329628.SGD","CBTA","AMDL","LU1935043536.SGD","LU0070302665.USD","LU0957808578.USD","IE00BKVL7J92.USD","IE0034235188.USD","LU2347655073.USD","LU0072462426.USD","LU0742534661.SGD","TSDD","ILDR","THNR","LU1674673428.USD","BK4573","IE00BK4W5L77.USD","LU1951198990.SGD","LU1861215975.USD","LU0187121727.USD","IE0005OL40V9.USD","TEST","LU0308772762.SGD","LU2543165471.USD","USXF","LU0203202063.USD","DRIV","LU1670711040.USD","LU1670627923.USD","METQ","BPI","IE000KEQY171.SGD","NVOX","LU2505996681.GBP","BK4598","BK4077","LU2247934214.USD","BK4511","LU1935042488.USD","LU0949170426.SGD","ARKB","LU0211328371.USD","LU0320765059.SGD","BK4023","LU1718418525.SGD","SG9999014880.SGD","SINTCmain","LU0661504455.SGD","LU2360107168.USD","LU0011850046.USD","CBTY","LU1116320737.USD","AMDG","BK4507","IE00BQXX3C00.GBP","SBIT","LU0053666078.USD","LU2360032135.SGD","LU1935042215.USD","LU1868836591.USD","IBIT","LU1116320901.HKD","LU0251132253.USD","BK4604","LU2272731600.USD","SG9999018865.SGD","IE000SO60NU8.SGD","SG9999017495.SGD","BK4585","BK4579","IE00BQXX3D17.EUR","IE00B19Z3B42.SGD","XDAT","IE00BFSS7M15.SGD","BK4555","LU0672654240.SGD","BK4575","LU1551013425.SGD","LU0949170772.SGD","CBOA","LU2456880835.USD","BTCW","IE000BZT7R73.USD","PPH","BAI","LU0211327993.USD","BK4516","LU0738911758.USD","BK4612","LU1923623000.USD","LU1267930813.SGD","LU1435385759.SGD","LU1974910355.USD","LU1629891620.HKD","LU0889565833.HKD","LU0061474705.USD","BITI","LU0553294199.USD","LU1989764748.USD","LU1868836757.USD","LU2168564495.EUR","LU0726765562.USD","LU0320765489.SGD","IE000F7OJYX1.SGD","LU0784385170.HKD","AMDW","LU0345769631.USD","SG9999014898.SGD","07366","IE00BN29S564.USD","BK4554","LIT","LU1839511570.USD","LU0354030438.USD","LU2242649171.HKD","LU2750360997.AUD","LU0096362180.USD","QBF","LU2756315664.SGD","BK4605","SOCL","LU0390134368.USD","LU1003077747.HKD","LU2361044949.HKD","BITB","AMDS","LU0198837287.USD","LU0203347892.USD","LU2249611893.SGD","LU2592432038.USD","LU0795875169.SGD","LU0079474960.USD","IE00B19Z9505.USD","BFAP","NVO","LU2471134796.USD","BK4587","LU2098885051.SGD","LU2347655156.SGD","ARTY","BTC","IE00BJTD4N35.SGD","LU0642271901.SGD","BTC.USD.CC","IE00B7KXQ091.USD","LU0345770308.USD","LU0784383803.USD","LU1989772840.SGD","XNTK","BK4515","LU0225283273.USD","FBYY","LU1242518857.USD","SG9999001077.SGD","LU0985320562.USD","LU2322448791.USD","IE0000B7K699.USD","CHPS","LU2430703251.USD","LU0276348264.USD","LU1988902786.USD","METD","TSLS","FBX","LU1868837136.USD","LU0106261372.USD","AIQ","LU1548497426.USD","LU1084165304.USD","LU0477156953.USD","LU1852331112.SGD","LU0957791311.USD","RSPC","LU0648001328.SGD","LU0889566641.SGD","LU0265550946.USD","LU2054465674.USD","BK4614","FAI","LU0719512351.SGD","LU1992135399.USD","LU0052756011.USD","LU2213496289.HKD","TSLZ","LU1066051811.HKD","LU1035775433.USD","IE0004445239.USD","LU1235294995.USD","LU2764263039.SGD","SGXZ81514606.USD","BK4524","IE00B4JS1V06.HKD","BTCI","LU0820561818.USD","LU1732800096.USD","BK4125","LU0979878070.USD","LU1804176565.USD","LU2357627491.SGD","LU2417539215.USD","BK4548","LU0157215616.USD","IE00B775H168.HKD","LU0321505868.SGD","IE000WAW04H5.SGD","LU2462591350.SGD","IE00BJLML261.HKD","EZBC","FCOM","LINT","LU0943347566.SGD","IE00B1XK9C88.USD","LU2264538146.SGD","TSL","LU1366333091.USD","LU2602419157.SGD","LU1861559042.SGD","LU0823421416.USD","LU2168563687.JPY","LU1670710661.SGD","LU1066051225.USD","LU1551013342.USD","TSLO","LU1496350502.SGD","BK4550","LU2552382132.HKD","STSLAmain","LU0316494557.USD","BITY","LU1989772923.USD","WANT","BK4534","BK4599","LU0256863902.USD","LU0690374961.EUR","LU1868837300.USD","LU2403377893.USD","LU2461242641.AUD","LU1803068979.SGD","TSLW","WUGI","LU1232071149.USD","LU0267386448.USD","BK4099","SGXZ23171101.USD","LU1697837992.HKD","LU2108987350.USD","IE00B7SZLL34.SGD","LU0234572021.USD","LU0912757837.SGD","LU0345769128.USD","BK4535","TSLL","BK4512","LU1917777945.USD","LU2746668461.USD","LU2750360641.GBP","TSYY","LU0251131958.USD","LU2931357623.SGD","LU2237957811.SGD","GB00B4LPDJ14.GBP","LU0127658192.USD","LU0980610538.SGD","BK4533","LU0878866978.SGD","SG9999001424.SGD","NVOC","LU2326559502.SGD","TTEQ","LU1720051108.HKD","LU2250418816.HKD","09766","LU1564329461.SGD","LU0109391861.USD","INT","IE00BFSS8Q28.SGD","LU2133065610.SGD","BTCC","LU2361045086.USD","LU0820562030.AUD","LU0274383776.USD","LU0640476718.USD","BTCO","LU2023250330.USD","LU2896262040.SGD","PARA","TSLP","CBXY","BTF","FBTC","LU1642822529.SGD","LU2381873111.SGD","LU2272731865.HKD","AMDY","TRUC","LU1791710582.SGD","LU1935043452.HKD","BETH","LU2087621335.USD","LU2471134879.HKD","LU1868836914.USD","TSLY","AMYY","BK4543","LU0314104364.USD","LU0048584097.USD","SG9999014914.USD","SMHX","LU0683600562.USD","FDRV","CBTO","BFJL","09366","SAMD0main","LU0985489474.SGD","BETE","LU0109392836.USD","LU0234570918.USD","LU0786609619.USD","TSLI","LU2125154935.USD","LU0545039389.USD","LU1059921491.USD","AMDD","LU1145028129.USD","SMH","LU2764263203.CNY","LU1791710400.SGD","LU2065169927.USD","IE00BZ1G4Q59.USD","SG9999002224.SGD","HK0000914686.HKD","TLA","LU2756315318.SGD","LU2430703095.HKD","FBL","BITO","IE000ITXATA3.USD","XLC","LU2458330169.SGD","METV","IE0001KFT4U8.USD","LU1935043023.USD","SG9999015952.SGD","BITU","INYY","LU1992135472.HKD","BK4108","IE000YTNTUN2.SGD","LU0345770993.USD","SGXZ80539844.SGD","LU1571399168.USD","LU0417517546.SGD","LU0354030511.USD","LU1153585028.USD","LU2552382215.SGD","CBXA","LU0133085943.USD","LEGR","LU0215105999.USD","INTC","LU2065170008.USD","LU0466842654.USD","DAMD","LU0048573561.USD","SOXY","LU2462157665.USD","LU1261432733.SGD","LU0795875086.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669227149","title":"Viking Therapeutics Reports Strong Obesity Drug Maintenance Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669227149","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669227149?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:30","pubTimestamp":1790076623,"startTime":"0","endTime":"0","summary":"Viking Therapeutics ( ($VKTX) ) has issued an announcement. On September 22, 2026, Viking Therapeutics reported positive top-line data from a maint...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/viking-therapeutics-reports-strong-obesity-drug-maintenance-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/viking-therapeutics-reports-strong-obesity-drug-maintenance-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","OZEM","VKTX","BK4139","BK4599","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149350","title":"Viking Therapeutics Shares Rise 38% Premarket After Experimental Drug Maintains Weight Loss in Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149350","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149350?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:19","pubTimestamp":1790075970,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VKTX","BK4588","BK4599","OZEM","BK4585","THNR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669146733","title":"Viking Therapeutics' Obesity Drug Shows 22% Weight Loss in Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2669146733","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669146733?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:12","pubTimestamp":1790075521,"startTime":"0","endTime":"0","summary":"Viking Therapeutics' obesity drug shows 22% weight loss in studySept 22 (Reuters)-Viking TherapeuticsVKTX.Osaid on Tuesday its experimental GLP-1 obesity drug helped patients lose 22% of their body weight after 33 weeks of weekly treatment in a maintenance study.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0OG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VKTX","BK4585","BK4588","BK4599","OZEM","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669493381","title":"Viking Therapeutics reports ‘positive’ results from maintenance study of VK2735","url":"https://stock-news.laohu8.com/highlight/detail?id=2669493381","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669493381?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:10","pubTimestamp":1790075445,"startTime":"0","endTime":"0","summary":"Viking Therapeutics (VKTX) announced positive top-line results from the company’s maintenance study of VK2735, the company’s dual agonist of the gl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viking-therapeutics-reports-positive-results-from-maintenance-study-of-vk2735-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viking-therapeutics-reports-positive-results-from-maintenance-study-of-vk2735-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4588","THNR","VKTX","OZEM","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669179146","title":"Viking Therapeutics Reports Vk2735 Maintenance Trial Keeps up to 97% of Weight Loss with Every-Other-Week Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669179146","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669179146?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:05","pubTimestamp":1790075134,"startTime":"0","endTime":"0","summary":"Viking Therapeutics reports VK2735 maintenance trial keeps up to 97% of weight loss with every-other-week dosingViking Therapeutics reported positive topline results from a maintenance study of obesit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL3vJdWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OZEM","BK4599","BK4585","BK4588","THNR","BK4139","VKTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":12,"totalSize":295,"code":"91000000","status":"200"}]}}